ABOUT THE PROJECT
Current early detection and gynaecological follow-up strategies are not effective. Our group has identified a potential cancer progression biomarker in apparently normal endometrium. We aim to validate the clinical utility of this assay in endometrial aspirates and minimally invasive samples in a national multicentric cohort of women with Lynch syndrome under surveillance. We are also conducting a comprehensive molecular characterization using NGS-based genomic approaches. Our final goal is the implementation of more personalised and effective surveillance and prevention strategies.
Fundació Roses Contra el Càncer
Cursa de la Dona Castelló d'Empúries
If you have any doubts or concerns about this research team, contact us by filling this form